RNF135 抗体 (AA 199-248)
Quick Overview for RNF135 抗体 (AA 199-248) (ABIN6735906)
抗原
See all RNF135 抗体适用
宿主
克隆类型
标记
应用范围
- 
    
- 
                                            
抗原表位
 - AA 199-248
 - 
                                            
特异性
 - Human RNF135
 - 
                                            
预测反应
 - Percent identity by BLAST analysis: Human (100%) Dog, Bovine (92%) Guinea pig (90%) Mouse (85%).
 - 
                                            
纯化方法
 - Immunoaffinity purified
 - 
                                            
免疫原
 - 
                        Synthetic peptide located between aa199-248 of human RNF135 (Q8IUD6, NP_115698). Percent identity by BLAST analysis: Human, Gorilla (100%), Galago, Marmoset, Dog, Bovine (92%), Guinea pig (90%), Mouse (85%), Elephant (84%).
Type of Immunogen: Synthetic peptide - 
                                            
亚型
 - IgG
 
 - 
                                            
 - 
    
 - 
    
- 
                                            
应用备注
 - Approved: WB (0.2 - 1 μg/mL)
 - 
                                            
说明
 - 
                        
Target Species of Antibody: Human
 - 
                                            
限制
 - 仅限研究用
 
 - 
                                            
 - 
    
- 
                                            
状态
 - Lyophilized
 - 
                                            
溶解方式
 - After adding water, will consist of PBS buffer with 2 % sucrose
 - 
                                            
浓度
 - Lot specific
 - 
                                            
缓冲液
 - Lyophilized from PBS with 2 % sucrose
 - 
                                            
注意事项
 - Avoid repeat freeze-thaw cycles.
 - 
                                            
储存条件
 - 4 °C,-20 °C
 - 
                                            
储存方法
 - 
                        Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles. 
 - 
                                            
 - 
    
 -